← Evidence map

ArticlePloS one2012

The prevalence and cost of unapproved uses of top-selling orphan drugs.

Aaron S Kesselheim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 22363762